Copyright
©2014 Baishideng Publishing Group Inc.
World J Methodol. Dec 26, 2014; 4(4): 197-218
Published online Dec 26, 2014. doi: 10.5662/wjm.v4.i4.197
Published online Dec 26, 2014. doi: 10.5662/wjm.v4.i4.197
Figure 3 The chemical structure of the iron chelating drug deferiprone (L1).
Deferiprone can bind iron through the two molecules of oxygen. It is a bidentate chelator and at physiological pH three molecules of L1 are used for binding one molecule of iron.
- Citation: Kolnagou A, Kontoghiorghe CN, Kontoghiorghes GJ. Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases. World J Methodol 2014; 4(4): 197-218
- URL: https://www.wjgnet.com/2222-0682/full/v4/i4/197.htm
- DOI: https://dx.doi.org/10.5662/wjm.v4.i4.197